JLL Partners said that it will commence an offer for any issued or outstanding shares it does not already own in Patheon Inc. (TSX: PTI), a Canadian provider of contract development and manufacturing services to the global pharmaceutical industry. The offer would be for US$2 per share, or a 138% premium to last Friday’s closing price.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
